Viewing Study NCT03691051


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-02-22 @ 2:21 AM
Study NCT ID: NCT03691051
Status: UNKNOWN
Last Update Posted: 2023-09-25
First Post: 2018-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
Sponsor: Henan Cancer Hospital
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: HR-MBC-HN001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators